1992
DOI: 10.1111/j.1540-8159.1992.tb02949.x
|View full text |Cite
|
Sign up to set email alerts
|

Modification of Late Potentials by Intracoronary Ethanol Infusion

Abstract: Antiarrhythmic drugs have no consistent effects on the signal-averaged electrocardiogram (ECG) while successful surgical ablation of ventricular tachycardia is known to abolish late potentials. Ten patients with prior myocardial infarction had successful ablation of recurrent sustained ventricular tachycardia by selective ethanol infusion into a small coronary vessel supplying the tachycardia origin. Signal-averaged ECGs were performed before and after initially successful ablation in patients without pacemake… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1994
1994
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…All these observations suggest that the subtle changes of the SAECG can be used as an adjunctive tool to evaluate the efficacy of the RFCA. An additional evidence for this was provided by Dailey et al who demonstrated that intracoronary infusion of ethanol can eliminate the late potentials in SAECG and terminate the VT [ 21 ]. Notably, RMS40 was not affected by the RFCA and did not show any difference between patients with and without VT recurrence, suggesting rather low sensitivity to detect modifications of the arrhythmogenic substrate and therefore can possibly be omitted as a component of the SAECG.…”
Section: Discussionmentioning
confidence: 99%
“…All these observations suggest that the subtle changes of the SAECG can be used as an adjunctive tool to evaluate the efficacy of the RFCA. An additional evidence for this was provided by Dailey et al who demonstrated that intracoronary infusion of ethanol can eliminate the late potentials in SAECG and terminate the VT [ 21 ]. Notably, RMS40 was not affected by the RFCA and did not show any difference between patients with and without VT recurrence, suggesting rather low sensitivity to detect modifications of the arrhythmogenic substrate and therefore can possibly be omitted as a component of the SAECG.…”
Section: Discussionmentioning
confidence: 99%